Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...

ANKARA, TURKEY — A strategy that takes advantage of the C in ICD (implantable cardioverter defibrillator), in which the device delivers a shock aimed at restoring sinus rhythm in patients with atrial ...

Oral anticoagulant therapy with rivaroxaban is a safe alternative to Vitamin K antagonist (VKA) therapy in patients with atrial fibrillation who are undergoing elective cardioversion to restore a ...

Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a ...

Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...

A delay of 12 hours or longer to correct an abnormal cardiac rhythm from atrial fibrillation was associated with a greater risk of thromboembolic complications such as stroke, according to a study. A ...

Heart rhythm monitoring in the weeks before cardioversion therapy for atrial fibrillation/atrial flutter reduced the ...

Nicholas P. Gall, M.Sc., M.D., M.R.C.P.; Francis D. Murgatroyd, M.A., F.R.C.P., F.A.C.C. From these and subsequent studies, it became clear that cardioversion was ...

PRINCETON, N.J. & NEW YORK--Bristol-Myers Squibb Company and Pfizer Inc. today announced that the first patient has been enrolled into a Phase IV clinical trial called EMANATE (Eliquis evaluated in ...

Sweden: Researchers have found in a new study that pre-cardioversion rhythm monitoring using smartphone-based ...

I recently diagnosed atrial fibrillation in a 24-year-old man with new-onset chest pain, irregular palpitations, and heart rate >170 beats per minute. The patient has no history of drug or tobacco ...